The Potential In Fighting Against COVID-19 Drives The Antivirals Market


Antivirals Global Market Report 2021: COVID 19 Implications And Growth To 2030

The Business Research Company’s Antivirals Global Market Report 2021: COVID-19 Implications And Growth to 2030

LONDON, GREATER LONDON, UK, May 5, 2021 / — The demand for anti-viral drugs grew at a rapid pace due to the novel coronavirus outbreak. As there were no vaccines and potential treatments for COVID-19, companies were trying to repurpose existing drugs in the fight against the novel coronavirus. The use of certain existing anti-viral drugs for COVID-19 treatment is contributing to the growth of anti-viral drugs market. However, if any of these drugs under trials show further promising results in treating the coronavirus infection, the anti-viral market will see further growth.

Besides the potential for fighting against the coronavirus, increasing public-private funding for life science research globally is also expected to drive the growth of the global antiviral therapies market. There are several vaccines and drugs in the pipeline, some yet to be approved or launched. Governments around the world announced new grant funds for researchers in vaccines, treatment, and diagnostics. In March 2020, the Canadian government announced $214.6 million for coronavirus research. Wellcome and the Gates Foundation announced they are joining forces with the credit card company MasterCard in a $125 million push to speed up development of drugs for treating COVID-19 infections. Hence increasing public-private funding for life science research will enhance the research and development, which drives the growth of the COVID-19 anti-viral drug therapy market.

Read More On The Global Antivirals Market Report:

Global antiviral drugs market analysis shows the antiviral drugs market size and share expected to decline from $62.62 billion in 2020 to $52.13 billion in 2021 at a compound annual growth rate (CAGR) of -16.8%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The antiviral drugs market revenue is expected to reach $67.66 billion in 2025 at a CAGR of 6.7%.

The major players covered in the global antivirals market are AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd, AstraZeneca plc., Aurobindo Pharma, Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi, Regeneron Pharmaceuticals, Inc., Inovio Pharmaceuticals, Inc., Novavax, Inc., BioCryst Pharmaceuticals, Inc.

The antiviral drug market research report is segmented by drug class into DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, others, by application into HIV, hepatitis, herpes, influenza, others, and by type into branded, generic.

Antivirals Global Market Report 2021: COVID 19 Implications And Growth to 2030 is one of a series of new reports from The Business Research Company that provides antivirals market overview, forecast antivirals market size and growth for the whole market, antivirals market segments, and geographies, antivirals market trends, antivirals market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Antivirals Market Report:

Here Is A List Of Similar Reports By The Business Research Company:

Anti-Infective Drugs Market – By Type Of Product (Antibiotics, Antivirals, Antifungals And Others (Including Anthelminthic And Antiprotozoal Drugs)), And By Region, Opportunities And Strategies – Global Forecast To 2022

COVID-19 Drug Associated APIs Global Market Report 2021: COVID-19 Growth And Change To 2030

Pharmaceutical Drugs Market – By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

Interested to know more about The Business Research Company?
Read more about us at

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media: